Prosecution Insights
Prosecution Insights
Tech Center 1600 • Art Units: 1614 1617 1624
This examiner grants 46% of resolved cases
| App # | Title | Status | Assignee |
|---|---|---|---|
| 19366427 | A Method and Composition for an Improved Bioavailability Delivery System | Final Rejection | Americana Pharma LLC |
| 18870206 | ANTIVIRAL COMPOSITION AND MEMBER HAVING SAID COMPOSITION AT SURFACE THEREOF | Non-Final OA | SHIN-ETSU CHEMICAL CO., LTD. |
| 18862364 | DOSAGE FORM WITH DRUG RELEASE AT PH 3 TO 6 USING DOUBLE COATING SYSTEM WITH AT LEAST ONE RELEASE ACCELERATION AGENT | Non-Final OA | Evonik Operations GmbH |
| 18850154 | FORMULATIONS COMPOSED OF CATIONIC LIPIDS AND POLY(LACTIC-CO-GLYCOLIC ACID) FOR THE DELIVERY OF POLYNUCLEOTIDES INTO CELLS | Non-Final OA | Evonik Operations GmbH |
| 17777002 | FIBER REINFORCED COMPOSITIONS AND METHODS OF MANUFACTURE FOR MEDICAL DEVICE APPLICATIONS | Final Rejection | Evonik Operations GmbH |
| 18697593 | PIGMENT SUSPENSION AND COSMETIC AGENT PREPARED USING THE PIGMENT SUSPENSION | Final Rejection | HENKEL AG & CO. KGAA |
| 18710858 | CHOLINE-BETAINE BASED ADJUVANTS FOR HERBICIDES | Non-Final OA | SPECIALTY OPERATIONS FRANCE |
| 17633038 | DISSOLVABLE VITAMIN C AND RETINOL FILM | Non-Final OA | Mary Kay Inc. |
IP Author analyzes examiner patterns and generates tailored response strategies with the highest chance of allowance.
Build Your Strategy